Company Filing History:
Years Active: 2013
Title: **Hanne Van Gorp: Pioneer in Virology and Cell Permissiveness**
Introduction
Hanne Van Gorp, an innovative inventor based in Merelbeke, Belgium, has made significant contributions to the field of virology. With a focused expertise in cellular interactions with viruses, particularly those affecting livestock, her work has potential implications for vaccine development and disease diagnosis in veterinary medicine.
Latest Patents
Hanne Van Gorp holds one notable patent titled "Permissive cells and uses thereof." This invention primarily addresses methods for determining the permissiveness of a cell for viruses belonging to the families Arteriviridae, Coronaviridae, or Asfarviridae, with a specific emphasis on the Porcine Reproductive and Respiratory Syndrome Virus (PRRSV). The invention also outlines methods and compositions that aid in creating host cells that are permissive for these viruses, ultimately facilitating advancements in viral cultures and diagnostic methodologies.
Career Highlights
Hanne Van Gorp is affiliated with Universiteit Gent, where her research continues to evolve the understanding of viral permissiveness. Her contributions are vital for combating diseases in swine, which can have significant economic impacts on the agricultural sector. The insights provided by her patent hold promise for advancements in veterinary therapeutics and diagnostics.
Collaborations
Throughout her career, Hanne has collaborated closely with esteemed colleagues such as Peter Delputte and Hans Nauwynck. These partnerships have fostered an environment of innovation and scientific inquiry that enhances the rigor and applicability of their research findings in virology.
Conclusion
Hanne Van Gorp exemplifies the spirit of innovation in the realm of virology. Her work not only advances scientific knowledge but also seeks to improve practical applications for disease management in livestock. With her groundbreaking patent and collaborative efforts, she continues to pave the way for future advancements in the field.